Drug details
Retacrit (epoetin alfa-epbx injection)
type of Erythropoiesis-Stimulating Agents
Retacrit (epoetin alfa-epbx) Injection is an erythropoiesis-stimulating agent (ESA) indicated for treatment of anemia due to chronic kidney disease (CKD) in patients on dialysis and not on dialysis; zidovudine in patients with HIV-infection; the effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy; and reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery.
The drug is often used to treat HIV .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- fever,
- pain spreading to your jaw or shoulder,
- fluttering in your chest,
- seizure,
- blurred vision,
- pounding in your neck or ears,
- constipation,
- dry mouth,
- wheezing,
- fainting,
- sweating,
- chest pain or pressure,
- unusual tiredness,
- sore throat,
- burning eyes,
- skin pain,
- red or purple skin rash with blistering and peeling,
- increased thirst,
- increased urination,
- fruity breath odor,
- irregular heartbeats,
- sudden numbness or weakness (especially on one side of the body),
- slurred speech,
- problems with vision or balance,
- nosebleeds
- leg cramps,
- numbness or tingling,
- severe dizziness,
- muscle weakness or limp feeling,
- sudden severe headache,
- anxiety, and
- rapid pulse,
- pain, swelling, warmth, redness, cold feeling, pale appearance of an arm or leg,
The following drugs are related to Retacrit, either as a replacement or used together:
- Triferic AVNU (ferric pyrophosphate citrate injection)
- Folic Acid (folic acid)
- Glofil-125 (sodium iothalamate i-125 injection solution)